Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Anderson Website

Stephen K. Anderson, Ph.D.

Selected Publications

1)  Belanger S, Tai LH, Anderson SK, Makrigiannis AP.
Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome.
Genes Immun. 2008.
[Journal]
2)  Thomas R, Yamada E, Alter G, Martin MP, Bashirova AA, Norman PJ, Altfeld M, Parham P, Anderson SK, McVicar DW, Carrington M.
Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?.
J. Immunol. 180: 6743-50, 2008.
[Journal]
3)  Martin MP, Pascal V, Yeager M, Phair J, Kirk GD, Hoots K, O'brien SJ, Anderson SK, Carrington M.
A mutation in KIR3DS1 that results in truncation and lack of cell surface expression.
Immunogenetics. 2007.
[Journal]
4)  Martin MP, Pascal V, Yeager M, Phair J, Kirk GD, Hoots K, O'brien SJ, Anderson SK, Carrington M.
A mutation in KIR3DS1 that results in truncation and lack of cell surface expression.
Immunogenetics. 2007.
[Journal]
5)  Ivanova AV, Ivanov SV, Pascal V, Lumsden JM, Ward JM, Morris N, Tessarolo L, Anderson SK, Lerman MI.
Autoimmunity, spontaneous tumourigenesis, and IL-15 insufficiency in mice with a targeted disruption of the tumour suppressor gene Fus1.
J. Pathol. 211: 591-601, 2007.
[Journal]
6)  Pascal V, Yamada E, Martin MP, Alter G, Altfeld M, Metcalf JA, Baseler MW, Adelsberger JW, Carrington M, Anderson SK, McVicar DW.
Detection of KIR3DS1 on the Cell Surface of Peripheral Blood NK Cells Facilitates Identification of a Novel Null Allele and Assessment of KIR3DS1 Expression during HIV-1 Infection.
J. Immunol. 179: 1625-33, 2007.
[Journal]
7)  Davies GE, Locke SM, Wright PW, Li H, Hanson RJ, Miller JS, Anderson SK.
Identification of bidirectional promoters in the human KIR genes.
Genes Immun. 8: 245-53, 2007.
[Journal]
8)  Stulberg MJ, Wright PW, Dang H, Hanson RJ, Miller JS, Anderson SK.
Identification of distal KIR promoters and transcripts.
Genes Immun. 8: 124-30, 2007.
[Journal]
9)  Anderson SK, Makrigiannis AP.
Ly49L.
UCSD-Nature Molecule Pages. 1, 2007.
Full Text Article. [Journal]
10)  Anderson SK, Makrigiannis AP.
Ly49O.
UCSD-Nature Molecule Pages. 1, 2007.
Full Text Article. [Journal]
11)  Anderson SK, Makrigiannis AP.
Ly49P.
UCSD-Nature Molecule Pages. 1, 2007.
Full Text Article. [Journal]
12)  Anderson SK, Makrigiannis AP.
Ly49V.
UCSD-Nature Molecule Pages. 1, 2007.
Full Text Article. [Journal]
13)  Pascal V, Nathan NR, Claudio E, Siebenlist U, Anderson SK.
NF-{kappa}B p50/p65 Affects the Frequency of Ly49 Gene Expression by NK Cells.
J. Immunol. 179: 1751-9, 2007.
[Journal]
14)  Pascal V, Stulberg MJ, Anderson SK.
Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough!.
Immunol. Rev. 214: 9-21, 2006.
[Journal]
15)  Anderson S.
Transcriptional regulation of NK cell receptors.
Curr Top Microbiol Immunol. 298: 59-75, 2006.
[Journal]
16)  Saleh A, Davies GE, Pascal V, Wright PW, Hodge DL, Cho EH, Lockett SJ, Abshari M, Anderson SK.
Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation.
Immunity. 21: 55-66, 2004.
[Journal]

This page was last updated on 8/5/2008.